These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26198922)

  • 1. Immature dendritic cell exosomes suppress experimental autoimmune myasthenia gravis.
    Bu N; Wu HQ; Zhang GL; Zhan SQ; Zhang R; Fan QY; Li YL; Zhai YF; Ren HW
    J Neuroimmunol; 2015 Aug; 285():71-5. PubMed ID: 26198922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis.
    Yin W; Ouyang S; Luo Z; Zeng Q; Hu B; Xu L; Li Y; Xiao B; Yang H
    Inflammation; 2017 Aug; 40(4):1460-1473. PubMed ID: 28523463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
    Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
    J Neuroinflammation; 2016 Jan; 13():8. PubMed ID: 26757900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.
    Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P
    Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis.
    Chae CS; Kwon HK; Hwang JS; Kim JE; Im SH
    PLoS One; 2012; 7(12):e52119. PubMed ID: 23284891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes derived from statin-modified bone marrow dendritic cells increase thymus-derived natural regulatory T cells in experimental autoimmune myasthenia gravis.
    Zhang P; Liu RT; Du T; Yang CL; Liu YD; Ge MR; Zhang M; Li XL; Li H; Dou YC; Duan RS
    J Neuroinflammation; 2019 Nov; 16(1):202. PubMed ID: 31679515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential.
    Gur-Wahnon D; Mizrachi T; Wald-Altman S; Al-Roof Higazi A; Brenner T
    J Autoimmun; 2014 Aug; 52():36-43. PubMed ID: 24423642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
    Aricha R; Reuveni D; Fuchs S; Souroujon MC
    J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells.
    Sheng JR; Li L; Ganesh BB; Vasu C; Prabhakar BS; Meriggioli MN
    J Immunol; 2006 Oct; 177(8):5296-306. PubMed ID: 17015715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action.
    Yu J; Zheng C; Ren X; Li J; Liu M; Zhang L; Liang L; Du W; Han ZC
    Scand J Immunol; 2010 Sep; 72(3):242-9. PubMed ID: 20696022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis.
    Qi H; Li J; Allman W; Saini SS; Tüzün E; Wu X; Estes DM; Christadoss P
    J Neuroimmunol; 2011 May; 234(1-2):165-7. PubMed ID: 21481948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH
    Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
    Fuchs S; Aricha R; Reuveni D; Souroujon MC
    J Autoimmun; 2014 Nov; 54():51-9. PubMed ID: 24970384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis.
    Sheng JR; Muthusamy T; Prabhakar BS; Meriggioli MN
    J Neuroimmunol; 2011 Dec; 240-241():65-73. PubMed ID: 22099723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats.
    Yang X; Meng S; Jiang H; Zhu C; Wu W
    J Surg Res; 2011 Dec; 171(2):826-32. PubMed ID: 20828738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.